Dustin B. Hammers

Dustin B. Hammers, PhD

Languages spoken: English

Academic Information

Departments Adjunct - Neurology

Board Certification

  • American Board of Professional Psychology (Sub: Clinical Neuropsychology)

Dr. Dustin Hammers is a board certified neuropsychologist who specializes in the assessment of neurodegenerative disorders. He became an adjunct faculty member in 2021 after transitioning from associate professor at the University of Utah to Indiana University. He currently serves as the site-PI for the Kronos Early Estrogen Prevention Study (KEEPS) Continuation study and collaborates on a number of projects throughout the Department of Neurology.

Education History

Postdoctoral Fellowship University of Michigan Healthcare System, Department of Psychiatry, Neuropsychology Section
 Postdoctoral Fellow
Veterans Affairs Ann Arbor and University of Michigan Healthcare System, Department of Psychology
 Intern
Doctoral Training Ohio University, Department of Psychology, Clinical Health Track
 PhD
Ohio University, Department of Psychology, Clinical Health Track
 MS
Undergraduate Allegheny College
 BS

Selected Publications

Journal Article

  1. Hammers DB, Kostadinova R, Unverzagt F, Apostolova L (2022). Assessing and validating reliable change across ADNI protocols. J Clin Exp Neuropsychol.
  2. Ikanga, J, Taiwo, Z, Lengu, K, Epenge, E, Esambo, H, Gikelekele, G, Esilakoy, Kavugho, I, Mampunza, S, Hammers, DB, Stringer, A, Spencer, RJ (2022). Developing Learning Slope Scores for the African Neuropsychology Battery in a Sample of Healthy Congolese. J Int Neuropsychol Soc.
  3. Dixon A, Porter S, Suhrie K, Hammers D, Duff K (2022). Predicting daily functioning with the modified Telephone Interview for Cognitive Status. Aging Clin Exp Res.
  4. Hammers, DB, Duff, K, Apostolova, LG (2022). Examining the role of repeated test exposure over 12 months across ADNI protocols. Alzheimers Dement (Amst).
  5. Hammers DB, Spencer RJ, Apostolova LG (2022). Validation of and demographically-corrected normative data for the Learning Ratio derived from the RAVLT in robustly intact older adults. Arch Clin Neuropsychol.
  6. Suhrie K, Hammers D, Porter S, Dixon A, King J, Anderson J, Duff K, Hoffman J (2021). Predicting Biomarkers in Intact Older Adults and those with Amnestic Mild Cognitive Impairment, and mild Alzheimer’s Disease Using the Repeatable Battery for the Assessment of Neuropsychological Status. J Clin Exp Neuropsychol.
  7. Hammers DB, Suhrie K, Dixon A, Gradwohl B, Archibald Z, King J, Spencer R, Duff K, Hoffman J (2021). Relationship between a novel learning slope metric and Alzheimer’s disease biomarkers. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn.
  8. Hammers DB, Duff K, Spencer R (2021). Demographically-corrected normative data for the HVLT-R, BVMT-R, and Aggregated Learning Ratio values in a sample of older adults. J Clin Exp Neuropsychol.
  9. Hammers D, Suhrie K, Dixon A, Gradwohl B, Duff K, Spencer R (2021). Validation of HVLT-R, BVMT-R, and RBANS learning slope scores along the Alzheimer’s continuum. Arch Clin Neuropsychol.
  10. Hammers DB, Miranda M, Abildskov TJ, Tate DF, Wilde EA, Spencer RJ (2021). Consideration of Different Scoring Approaches for a Verbal Incidental Learning Measure from the WAIS-IV Using Hippocampal Volumes. Appl Neuropsychol Adult.
  11. Duff K, Ying J, Suhrie K, Dalley B, Atkinson T, Porter S, Dixon A, Hammers DB, Wolinsky F (2021). Computerized cognitive training in amnestic Mild Cognitive Impairment: A randomized clinical trial. J Geriatr Psychiatry Neurol.
  12. Porter SM, Dixon A, Suhrie K, Hammers DB, Duff K (2021). Longitudinal changes on the Independent Living Scale in Amnestic Mild Cognitive Impairment. Appl Neuropsychol Adult.
  13. Hammers DB, Gradwohl B, Kucera A, Abildskov T, Wilde E, Spencer R (2020). Preliminary validation of a measure for learning slope for the HVLT-R and BVMT-R in older adults. Cogn Behav Neurol.
  14. Hammers DB, Stolwyk R, Harder L, Cullum MC (2020). A Survey of International Clinical Teleneuropsychology Service Provision Prior to and in the Context of COVID-19. https://doi.org/10.1080/13854046.2020.1810323. Clin Neuropsychol.
  15. Hammers DB, Suhrie KR, Porter SM, Dixon AM, and Duff K (2020). Validation of one-year reliable change in the RBANS for community-dwelling older adults with Mild Cognitive Impairment. doi: 10.1080/13854046.2020.1807058. Clin Neuropsychol.
  16. Duff K, Porter S, Dixon A, Suhrie K, Hammers DB (2020). The Independent Living Scale in Amnestic Mild Cognitive Impairment: Relationships to demographic variables and cognitive performance. J Clin Exp Neuropsychol.
  17. Spencer R, Gradwohl B, Williams T, Kordovski V, Hammers D (2020). Developing Learning Slope Scores for the Repeatable Battery for the Assessment of Neuropsychological Status. Appl Neuropsychol Adult.
  18. Hammers DB, Porter SM, Dixon AM, Suhrie KR, Duff D (2020). Validating one-year reliable change methods. Arch Clin Neuropsychol.
  19. Hammers DB, Suhrie KR, Dixon AM, Porter SM, Duff K (2020). Validation of one-week reliable change methods in cognitively intact community-dwelling older adults. Aging, Neuropsychology, and Cognition.
  20. Duff K, Hammers DB (2020). Practice effects in Mild Cognitive Impairment: A validation of Calamia et al. (2012). Clin Neuropsychol.
  21. Hammers DB, Kucera A, Spencer RJ, Abildskov TJ, Archibald ZG, Hoffman JM, Wilde EA (2020). Examining the Relationship between a Verbal Incidental Learning Measure from the WAIS-IV and Neuroimaging Biomarkers in Older Adults. Dev Neuropsychol.
  22. Hammers DB, Suhrie K, Porter S, Dixon A, Duff K (2020). Generalizability of reliable change equations for the RBANS over one year in community-dwelling older adults. https://doi.org/10.1080/13803395.2020.1740654. J Clin Exp Neuropsychol.
  23. Hammers DB, Suhrie KR, Dixon A, Porter S, Duff K (2020). Reliable change in cognition over 1 week in community-dwelling older adults: a validation and extension study. Arch Clin Neuropsychol.
  24. Hammers DB, Weisenbach SL (2020). Questioning the Effort Hypothesis that Depressed Patients Perform Disproportionately Worse on Effortful Cognitive Tasks. Percept Mot Skills.
  25. Hammers DB, Duff K (2019). Application of different standard error estimates in reliable change methods. Arch Clin Neuropsychol.
  26. Hammers D, Foster N, Hoffman J, Green T, Duff K (2019). Neuropsychological, psychiatric, and functional correlates of clinical trial enrollment. J Prev Alzheimers Dis, 6(4), 242-247.
  27. Weisenbach SL, Kim J, Hammers D, Konopacki K, Koppelmans V (2019). Linking Late Life Depression and Alzheimer’s Disease: Mechanisms and Resilience. Curr Behav Neurosci Rep, 6, 103-112.
  28. Duff, K, Dalley, B, Suhrie, K, Hammers, D (2019). Predicting Premorbid Scores on the Repeatable Battery for the Assessment of Neuropsychological Status and their Validation in an Elderly Sample. Arch Clin Neuropsychol, 34(3), 395-402.
  29. Hammers, DB, Kucera AM, Card, SC, Tolle, KA, Atkinson, TJ, Duff, K, Spencer, RJ (2018). Validity of a verbal incidental learning measure from the WAIS-IV in older adults. Appl Neuropsychol Adult, 25(3), 266-273.
  30. Ryan, K, Hammers, D, DeLeon, A, Bilen, H, Frey, K, Burke, J, Albin, R, Barbas, N, Heidebrink, J, Giordani, G (2017). Agreement among neuropsychological and behavioral data and PiB findings in diagnosing Frontotemporal Dementia. J Clin Neurosci, 44, 128-132.
  31. Hammers, DB, Atkinson, TJ, Dalley, BCA, Suhrie, KR, Horn, KP, Rasmussen, KM, Beardmore, BE, Burrell, LD, Duff, K, amp Hoffman, JM (2017). Amyloid Positivity using [18F]Flutemetamol-PET and Cognitive Deficits in Non-Demented Community-Dwelling Older Adults. Am J Alzheimers Dis Other Demen, 32(6), 320-328.
  32. Hammers, DB, Atkinson, T J, Dalley, B C A, Suhrie, K R, Beardmore, B, Burrell, L, Horn, K P, Rasmussen, K M, Foster, N L, Duff, K, amp Hoffman, J M (2017). Relationship between 18F-Flutemetamol Uptake and RBANS Performance in Non-Demented Community-Dwelling Older Adults. Clin Neuropsychol, 31(3), 531-543.
  33. Duff, K, Hammers, D B, Dalley, B C A, Suhrie, K R, Atkinson, T J, Rasmussen, K M, Horn, K P, Beardmore, B E, Burrell, L D, Foster, N L, amp Hoffman, JM (2017). Short-term practice effects and amyloid deposition: Providing information above and beyond baseline cognition. J Prev Alzheimers Dis, 4(2), 87-92.
  34. K Duff, T Atkinson, K Suhrie, B Dalley, S Schaefer, amp D Hammers (8/19/2016). Short-term practice effects in mild cognitive impairment: Evaluating different methods of change. J Clin Exp Neuropsychol, 39(4), 396-407.
  35. Hammers, D, Ramirez, G, Persad, C, Heidebrink, J, Barbas, N, Giordani, B (09/03/2015). Diagnostic Profiles of Patients Differentially Failing Executive Functioning Measures. Am J Alzheimers Dis Other Demen, 31(3), 214-22.
  36. Hammers DB, Jung M, Pressler SJ, Sullivan BJ, Koelling T, Giordani B (2013). Clinical utility of auditory memory testing in a heart failure population. J Cardiovasc Nurs, 28(5), 444-52. (Read full article)
  37. Duff K, Foster NL, Dennett K, Hammers DB, Zollinger LV, Christian PE, Butterfield RI, Beardmore BE, Wang AY, Morton KA, amp Hoffman JM (2013). Amyloid deposition and cognition in older adults: The effects of premorbid intellect. Arch Clin Neuropsychol, 28(7), 665-71.
  38. Hammers D, Spurgeon E, Ryan K, Persad C, Barbas N, Heidebrink J, Darby D, Giordani B (2012). Validity of a brief computerized cognitive screening test in dementia. J Geriatr Psychiatry Neurol, 25(2), 89-99. (Read full article)
  39. Hammers D, Spurgeon E, Ryan K, Persad C, Heidebrink J, Barbas N, Albin R, Frey K, Darby D, Giordani B (2011). Reliability of repeated cognitive assessment of dementia using a brief computerized battery. Am J Alzheimers Dis Other Demen, 26(4), 326-33. (Read full article)
  40. Hammers DB, Suhr JA (2010). Neuropsychological, impulsive personality, and cerebral oxygenation correlates of undergraduate polysubstance use. J Clin Exp Neuropsychol, 32(6), 599-609. (Read full article)
  41. Suhr J, Hammers D (2010). Who fails the Iowa Gambling Test (IGT)? Personality, neuropsychological, and near-infrared spectroscopy findings in healthy young controls. Arch Clin Neuropsychol, 25(4), 293-302. (Read full article)
  42. Suhr J, Hammers D, Dobbins-Buckland K, Zimak E, Hughes C (2008). The relationship of malingering test failure to self-reported symptoms and neuropsychological findings in adults referred for ADHD evaluation. Arch Clin Neuropsychol, 23(5), 521-30. (Read full article)
  43. Turchik J, Karpenko V, Hammers D, McNamara J (2007). Practical and ethical assessment issues in rural, impoverished, and managed care settings. Prof Psychol Res Pr, 38(2), 158-168.

Book Chapter

  1. Hammers D, Duff K, amp Chelune G (2015). Assessing change of cognitive trajectories over time in later life. In N.A. Pachana and Laidlaw (Eds.), Oxford Handbook of Clinical Geropsychology. Oxford: Oxford University Press.

Abstract

  1. Atkinson, T J, Hammers, D B, Dalley, B C A, Suhrie, K R, Beardmore, B, Burrell, L, Horn, K, Rasmussen, K, Duff, K, amp Hoffman, J M (11/2016). Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults. Annual Meeting of the Society for Neuroscience. [Abstract].